Literature DB >> 23329070

Ultra-low-molecular-weight heparins: precise structural features impacting specific anticoagulant activities.

Marcelo A Lima1, Christian Viskov, Frederic Herman, Angel L Gray, Eduardo H C de Farias, Renan P Cavalheiro, Guilherme L Sassaki, Debra Hoppensteadt, Jawed Fareed, Helena B Nader.   

Abstract

Ultra-low-molecular-weight heparins (ULMWHs) with better efficacy and safety ratios are under development; however, there are few structural data available. The main structural features and molecular weight of ULMWHs were studied and compared to enoxaparin. Their monosaccharide composition and average molecular weights were determined and preparations studied by nuclear magnetic resonance spectroscopy, scanning ultraviolet spectroscopy, circular dichroism and gel permeation chromatography. In general, ULMWHs presented higher 3-O-sulphated glucosamine and unsaturated uronic acid residues, the latter being comparable with their higher degree of depolymerisation. The analysis showed that ULMWHs are structurally related to LMWHs; however, their monosaccharide/oligosaccharide compositions and average molecular weights differed considerably explaining their different anticoagulant activities. The results relate structural features to activity, assisting the development of new and improved therapeutic agents, based on depolymerised heparin, for the prophylaxis and treatment of thrombotic disorders.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23329070     DOI: 10.1160/TH12-11-0795

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  2 in total

1.  Heparin dodecasaccharide containing two antithrombin-binding pentasaccharides: structural features and biological properties.

Authors:  Christian Viskov; Stefano Elli; Elena Urso; Davide Gaudesi; Pierre Mourier; Frederic Herman; Christian Boudier; Benito Casu; Giangiacomo Torri; Marco Guerrini
Journal:  J Biol Chem       Date:  2013-07-10       Impact factor: 5.157

Review 2.  Engineered heparins as new anticoagulant drugs.

Authors:  Deepika Vaidyanathan; Asher Williams; Jonathan S Dordick; Mattheos A G Koffas; Robert J Linhardt
Journal:  Bioeng Transl Med       Date:  2016-11-21
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.